Bioharvest Sciences Inc (BHST)

$4.70 -0.03 (-0.63%)
Market Cap 77.69M
Revenue (ttm) 25.19M
Net Income (ttm) -12.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -51.25%
Debt to Equity Ratio 0.78
Volume 14,100
Avg Vol 41,002
Day's Range N/A - N/A
Shares Out 16.43M
Stochastic %K 57%
Beta 1.12
Analysts Strong Sell
Price Target $12.75

Company Profile

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and function...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 604 689 5722
Fax: 604 685 9182
Address:
1140-625 Howe Street, Vancouver, Canada
BioHarvest_Sciences
BioHarvest_Sciences Feb. 19 at 4:59 PM
$BHST Roth Capital initiates Analyst coverage of BioHarvest Sciences (BHST) https://investing.com/news/analyst-ratings/rothmkm-initiates-bioharvest-sciences-stock-with-buy-rating-93CH-4512648
0 · Reply
erevnon
erevnon Feb. 19 at 11:45 AM
Roth Capital initiates coverage on BioHarvest Sciences $BHST at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
VolumeChaser
VolumeChaser Feb. 18 at 9:24 AM
$BHST Speculative structure where corporate actions drive valuation more than operations.
0 · Reply
sepsis74
sepsis74 Feb. 17 at 9:25 PM
$BHST there was a huge seller today. Volume was two what was normal. Someone is definitely dumping.
0 · Reply
sepsis74
sepsis74 Feb. 17 at 8:18 PM
$BHST Alyeska Investment Group has shown up as a 3.8% owner of Bioharvest as of the 12/31/25 13-F filing. Alyeska is a $35 billion equity hedge fund.
0 · Reply
FactorIntegration
FactorIntegration Feb. 17 at 2:55 PM
$BHST BHST or unknown micro-cap with minimal public information.
0 · Reply
breakoutian
breakoutian Feb. 17 at 8:21 AM
$BHST Obscure micro-cap; minimal information
0 · Reply
forgottenchuck
forgottenchuck Feb. 11 at 7:43 PM
$BHST what the foook has happen to the ceo of bioharvest, has he died. not a peep from jim in 6 weeks
0 · Reply
TradeMason
TradeMason Feb. 10 at 1:01 PM
$BHST is a biotech or pharmaceutical company; name not standard, indicating high risk.
0 · Reply
hoIdmybags
hoIdmybags Feb. 9 at 7:13 AM
$BHST OGs remember this was a cannabis stock. 100mil shelf is not very intriguing …
0 · Reply
Latest News on BHST
BioHarvest Sciences Issues Year End Shareholder Letter

Jan 7, 2026, 7:30 AM EST - 6 weeks ago

BioHarvest Sciences Issues Year End Shareholder Letter

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

Dec 18, 2025, 7:30 AM EST - 2 months ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

Dec 3, 2025, 7:30 AM EST - 2 months ago

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

BioHarvest Sciences Inc. (BHST) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 11:11 PM EST - 3 months ago

BioHarvest Sciences Inc. (BHST) Q3 2025 Earnings Call Transcript

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:05 PM EST - 3 months ago

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025

Nov 12, 2025, 8:42 AM EST - 3 months ago

BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares

Nov 10, 2025, 4:18 PM EST - 3 months ago

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

Nov 7, 2025, 7:30 AM EST - 3 months ago

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

BioHarvest Announces Proposed Public Offering of Common Stock

Nov 6, 2025, 4:37 PM EST - 3 months ago

BioHarvest Announces Proposed Public Offering of Common Stock

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

Nov 4, 2025, 7:30 AM EST - 4 months ago

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

Oct 30, 2025, 7:30 AM EDT - 4 months ago

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

Sep 22, 2025, 6:32 AM EDT - 5 months ago

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

BioHarvest Sciences Inc. (BHST) Virtual Investor Webinar Call (Transcript)

Sep 10, 2025, 7:45 PM EDT - 5 months ago

BioHarvest Sciences Inc. (BHST) Virtual Investor Webinar Call (Transcript)

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

Sep 10, 2025, 7:00 AM EDT - 5 months ago

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

Sep 2, 2025, 8:30 AM EDT - 6 months ago

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

BioHarvest Sciences Inc. (BHST) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 1:20 PM EDT - 7 months ago

BioHarvest Sciences Inc. (BHST) Q2 2025 Earnings Call Transcript

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 7:30 AM EDT - 7 months ago

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

Aug 4, 2025, 8:30 AM EDT - 7 months ago

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

Jul 23, 2025, 8:30 AM EDT - 7 months ago

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

Jun 4, 2025, 7:00 AM EDT - 9 months ago

BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

May 21, 2025, 8:30 AM EDT - 9 months ago

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings Call Transcript

May 15, 2025, 11:18 PM EDT - 10 months ago

BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings Call Transcript

BioHarvest Sciences Reports First Quarter 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 10 months ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

May 12, 2025, 8:30 AM EDT - 10 months ago

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

May 1, 2025, 8:30 AM EDT - 10 months ago

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

BioHarvest Sciences Inc. (BHST) Q4 2024 Earnings Conference Call Transcript

Mar 31, 2025, 8:54 PM EDT - 11 months ago

BioHarvest Sciences Inc. (BHST) Q4 2024 Earnings Conference Call Transcript

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 31, 2025, 4:05 PM EDT - 11 months ago

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

Mar 17, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

Mar 6, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

Mar 4, 2025, 8:30 AM EST - 1 year ago

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

Feb 18, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

Feb 12, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Jan 22, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Jan 8, 2025, 8:41 AM EST - 1 year ago

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

Dec 11, 2024, 6:00 AM EST - 1 year ago

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call Transcript

Nov 25, 2024, 7:01 PM EST - 1 year ago

BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call Transcript

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

Nov 25, 2024, 4:05 PM EST - 1 year ago

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

BioHarvest Launches VINIA SuperFood Functional Tea Line

Nov 25, 2024, 8:30 AM EST - 1 year ago

BioHarvest Launches VINIA SuperFood Functional Tea Line

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Nov 21, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

Nov 18, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

Nov 12, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

Nov 7, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

Oct 23, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

Oct 16, 2024, 8:47 AM EDT - 1 year ago

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board

Sep 20, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

Sep 12, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

Aug 29, 2024, 9:22 AM EDT - 1 year ago

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside

Aug 28, 2024, 9:56 AM EDT - 1 year ago

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

Aug 23, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

BioHarvest_Sciences
BioHarvest_Sciences Feb. 19 at 4:59 PM
$BHST Roth Capital initiates Analyst coverage of BioHarvest Sciences (BHST) https://investing.com/news/analyst-ratings/rothmkm-initiates-bioharvest-sciences-stock-with-buy-rating-93CH-4512648
0 · Reply
erevnon
erevnon Feb. 19 at 11:45 AM
Roth Capital initiates coverage on BioHarvest Sciences $BHST at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
VolumeChaser
VolumeChaser Feb. 18 at 9:24 AM
$BHST Speculative structure where corporate actions drive valuation more than operations.
0 · Reply
sepsis74
sepsis74 Feb. 17 at 9:25 PM
$BHST there was a huge seller today. Volume was two what was normal. Someone is definitely dumping.
0 · Reply
sepsis74
sepsis74 Feb. 17 at 8:18 PM
$BHST Alyeska Investment Group has shown up as a 3.8% owner of Bioharvest as of the 12/31/25 13-F filing. Alyeska is a $35 billion equity hedge fund.
0 · Reply
FactorIntegration
FactorIntegration Feb. 17 at 2:55 PM
$BHST BHST or unknown micro-cap with minimal public information.
0 · Reply
breakoutian
breakoutian Feb. 17 at 8:21 AM
$BHST Obscure micro-cap; minimal information
0 · Reply
forgottenchuck
forgottenchuck Feb. 11 at 7:43 PM
$BHST what the foook has happen to the ceo of bioharvest, has he died. not a peep from jim in 6 weeks
0 · Reply
TradeMason
TradeMason Feb. 10 at 1:01 PM
$BHST is a biotech or pharmaceutical company; name not standard, indicating high risk.
0 · Reply
hoIdmybags
hoIdmybags Feb. 9 at 7:13 AM
$BHST OGs remember this was a cannabis stock. 100mil shelf is not very intriguing …
0 · Reply
sepsis74
sepsis74 Feb. 2 at 9:43 PM
$BHST the lock-up from the November 7 offering at $7 expires on Feb. 5th. Is that what all the constant weakness has been about? Those guys aren't going to sell. There isn't enough liquidity for that. And they are down -30%.
0 · Reply
forgottenchuck
forgottenchuck Jan. 30 at 7:52 PM
$BHST CRICKETS AS USUALL
0 · Reply
hBarbarism
hBarbarism Jan. 28 at 8:51 PM
$BHST Yes partnership with Gatorade , Let’s goo
0 · Reply
sepsis74
sepsis74 Jan. 28 at 2:17 PM
$BHST all good news, but the stock is languishing.
1 · Reply
mankind1
mankind1 Jan. 28 at 1:05 AM
$BHST I was thinking... these drinks and chewables can be really big. I'd imagine Gatorade would be interested in working with them.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 25 at 3:30 AM
$BHST RSI: 57.58, MACD: -0.1615 Vol: 0.24, MA20: 5.23, MA50: 5.82 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
mankind1
mankind1 Jan. 8 at 5:12 PM
$BHST somebody give me something to think about
1 · Reply
mankind1
mankind1 Jan. 7 at 8:44 PM
$BHST getting some attention
0 · Reply
BioHarvest_Sciences
BioHarvest_Sciences Jan. 7 at 4:42 PM
$BHST News Release--> BioHarvest Issues Year End CEO Shareholder Letter. "2025 marked an important milestone for BioHarvest Sciences: our first full year as a NASDAQ-listed company, and we enter 2026 with an annualized revenue run rate exceeding US$36 million and gross margins above 60%..." Read full letter: https://bioharvest.com/bioharvest-sciences-issues-year-end-shareholder-letter/
0 · Reply
newsfile_corp
newsfile_corp Jan. 7 at 12:31 PM
https://nfne.ws/279690 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #AnnualResults #NASDAQ #In
0 · Reply
mankind1
mankind1 Jan. 5 at 6:43 AM
$BHST consolidation?
2 · Reply
forgottenchuck
forgottenchuck Jan. 2 at 6:50 PM
$BHST i cannot no longer trade bioharvest on charles schwab anymore. they call the stock a risk
1 · Reply